MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$52.76 2.70 (5.39%)
Open Price: 50.44
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients